Home
Conditions
Hemoglobinuria, Paroxysmal

Clinical trial condition

Hemoglobinuria, Paroxysmal

Explore clinical trials studying Hemoglobinuria, Paroxysmal. Study availability and eligibility vary by location and protocol.

10 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Hemoglobinuria, Paroxysmal trial results

Active, not recruiting

Post-authorization Safety Study of Iptacopan in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Using Data From the IPIG PNH Registry

NCT06903234

Conditions: Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +4 more
Locations: Novartis Investigative Site Basel, Switzerland

View Trial Details

Completed

Reduced Intensity Allogeneic PBSCT to Treat Hematologic Malignancies and Hematopoietic Failure States

NCT00997386

Conditions: Anemia, Anemia, Aplastic, Anemia, Hemolytic, +27 more
Locations: University Medical Center and UMC-North Clinic Tucson, Arizona, United States

View Trial Details

Completed

Eculizumab Pharmacokinetics/Pharmacodynamics Study in Pediatric/Adolescent Paroxysmal Nocturnal Hemoglobinuria (PNH)

NCT00867932

Conditions: Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +4 more
Locations: Orange, California, United States

Pensacola, Florida, United States

Memphis, Tennessee, United States

View Trial Details

Completed

Peripheral Blood Stem Cell Transplantation (PBSCT)From Haploidentical Related Donors

NCT00618969

Conditions: Anemia, Anemia, Aplastic, Anemia, Hemolytic, +26 more
Locations: Arizona Cancer Center/University Medical Center Tucson, Arizona, United States

View Trial Details

Completed

Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer

NCT00975975

Conditions: Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Anemia, +47 more
Locations: Indiana University Cancer Center Indianapolis, Indiana, United States

View Trial Details

Completed

The Molecular Biology of Paroxysmal Nocturnal Hemoglobinuria (PNH)

NCT00721864

Conditions: Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +15 more
Locations: University of Utah Salt Lake City, Utah, United States

View Trial Details

Completed

Stem Cell Transplantation for Patients With Hematologic Malignancies

NCT00152139

Conditions: Acute Lymphoblastic Leukemias, Acute Myelocytic Leukemia, Anemia, +31 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Completed

Eculizumab to Treat Paroxysmal Nocturnal Hemoglobinuria

NCT00098280

Conditions: Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +4 more
Locations: National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States

View Trial Details

Completed

Study of Safety in Hemolytic Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated With Eculizumab

NCT00122304

Conditions: Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +4 more
Locations: Norris Comprehensive Cancer Center Los Angeles, California, United States

Stanford University Medical Center, Division of Hematology Stanford, California, United States

Hartford Hospital, Cancer Clinical Research Office Hartford, Connecticut, United States

Cleveland Clinic Florida, Dept. of Clinical Research Weston, Florida, United States

View all 48 locations

View Trial Details

Completed

Study Using Eculizumab in Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients

NCT00122330

Conditions: Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +4 more
Locations: City of Hope National Medical Center, Div. of Hematology & Bone Marrow Transplant Duarte, California, United States

University of California at Los Angeles Los Angeles, California, United States

Scripps Cancer Center San Diego, California, United States

Stanford University Medical Center, Division of Hematology Stanford, California, United States

View all 43 locations

View Trial Details

Hemoglobinuria, Paroxysmal

Hemoglobinuria, Paroxysmal trial results

Related conditions